FP
EDIT icon

Flagship Pioneering’s Editas Medicine EDIT Stock Holding History

Flagship Pioneering’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1,674,435
Closed -$51.5M – 5
2017
Q4 		$51.5M Hold
1,674,435
– – 13.05% 3
2017
Q3 		$40.2M Sell
1,674,435
-1,701,749
-50% -$32.4M 13.45% 3
2017
Q2 		$56.7M Hold
3,376,184
– – 19.98% 3
2017
Q1 		$75.4M Sell
3,376,184
-79,132
-2% -$1.64M 20.03% 3
2016
Q4 		$56.1M Hold
3,455,316
– – 18.25% 3
2016
Q3 		$46.6M Buy
+3,455,316
New +$70.8M 12.73% 4

Other funds holding EDIT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Flagship Pioneering's EDIT Position: Q1 2018 in Review

Flagship Pioneering sold out of Editas Medicine (EDIT) in Q1 2018, closing a stake of 1,674,435 shares — an estimated $51.5M sold.

Flagship Pioneering first reported a position in EDIT in Q3 2016 and held it in 6 quarters. The position peaked at $75.4M in Q1 2017. 197 funds tracked by Wall St. Rank hold EDIT as of Q1 2018.

  • Flagship Pioneering reported no remaining Editas Medicine position as of Q1 2018 after selling out during the quarter.
  • Flagship Pioneering sold 1,674,435 Editas Medicine shares in Q1 2018, an estimated $51.5M.
  • Flagship Pioneering first reported a position in Editas Medicine in Q3 2016 and held it in 6 quarters.
  • Flagship Pioneering's Editas Medicine position peaked at $75.4M in Q1 2017.
  • 197 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2018.

Based on Flagship Pioneering's 13F filing for Q1 2018, filed 15 May 2018.